DATACENTREX INC (DTCX) Fundamental Analysis & Valuation

NASDAQ:DTCX • US2569181033

Current stock price

3.34 USD
+0.02 (+0.6%)
Last:

This DTCX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. DTCX Profitability Analysis

1.1 Basic Checks

  • In the past year DTCX has reported negative net income.
DTCX Yearly Net Income VS EBIT VS OCF VS FCFDTCX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 -1M -2M -3M

1.2 Ratios

  • DTCX has a Return On Assets of -7.74%. This is comparable to the rest of the industry: DTCX outperforms 40.65% of its industry peers.
  • With a Return On Equity value of -7.88%, DTCX perfoms like the industry average, outperforming 51.44% of the companies in the same industry.
Industry RankSector Rank
ROA -7.74%
ROE -7.88%
ROIC N/A
ROA(3y)-336.21%
ROA(5y)N/A
ROE(3y)-408.96%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DTCX Yearly ROA, ROE, ROICDTCX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 -200 -400 -600 -800

1.3 Margins

  • With an excellent Gross Margin value of 100.00%, DTCX belongs to the best of the industry, outperforming 99.64% of the companies in the same industry.
  • DTCX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 100%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
DTCX Yearly Profit, Operating, Gross MarginsDTCX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 -100K -200K -300K -400K -500K

6

2. DTCX Health Analysis

2.1 Basic Checks

  • DTCX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • DTCX has more shares outstanding than it did 1 year ago.
  • DTCX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
DTCX Yearly Shares OutstandingDTCX Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2M 4M 6M 8M
DTCX Yearly Total Debt VS Total AssetsDTCX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 1M 2M 3M 4M 5M

2.2 Solvency

  • DTCX has an Altman-Z score of 68.69. This indicates that DTCX is financially healthy and has little risk of bankruptcy at the moment.
  • DTCX has a Altman-Z score of 68.69. This is amongst the best in the industry. DTCX outperforms 98.56% of its industry peers.
  • A Debt/Equity ratio of 0.01 indicates that DTCX is not too dependend on debt financing.
  • DTCX's Debt to Equity ratio of 0.01 is fine compared to the rest of the industry. DTCX outperforms 63.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 68.69
ROIC/WACCN/A
WACC10.92%
DTCX Yearly LT Debt VS Equity VS FCFDTCX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 2M -2M 4M

2.3 Liquidity

  • A Current Ratio of 50.79 indicates that DTCX has no problem at all paying its short term obligations.
  • With an excellent Current ratio value of 50.79, DTCX belongs to the best of the industry, outperforming 98.92% of the companies in the same industry.
  • DTCX has a Quick Ratio of 50.79. This indicates that DTCX is financially healthy and has no problem in meeting its short term obligations.
  • DTCX's Quick ratio of 50.79 is amongst the best of the industry. DTCX outperforms 98.92% of its industry peers.
Industry RankSector Rank
Current Ratio 50.79
Quick Ratio 50.79
DTCX Yearly Current Assets VS Current LiabilitesDTCX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 1M 2M 3M 4M

0

3. DTCX Growth Analysis

3.1 Past

  • DTCX shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -7.09%.
  • DTCX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -66.67%.
EPS 1Y (TTM)-7.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-66.67%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
DTCX Yearly Revenue VS EstimatesDTCX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 500 1K 1.5K 2K

0

4. DTCX Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for DTCX. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DTCX Price Earnings VS Forward Price EarningsDTCX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DTCX Per share dataDTCX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. DTCX Dividend Analysis

5.1 Amount

  • DTCX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

DTCX Fundamentals: All Metrics, Ratios and Statistics

DATACENTREX INC

NASDAQ:DTCX (3/26/2026, 11:40:46 AM)

3.34

+0.02 (+0.6%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)12-23
Earnings (Next)N/A
Inst Owners3.92%
Inst Owner ChangeN/A
Ins Owners14.48%
Ins Owner Change90.67%
Market Cap101.47M
Revenue(TTM)700
Net Income(TTM)-4.00M
AnalystsN/A
Price TargetN/A
Short Float %4.18%
Short Ratio2.85
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 144956
P/FCF N/A
P/OCF N/A
P/B 2
P/tB 2.18
EV/EBITDA N/A
EPS(TTM)-0.5
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS1.67
TBVpS1.53
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -7.74%
ROE -7.88%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 100%
FCFM N/A
ROA(3y)-336.21%
ROA(5y)N/A
ROE(3y)-408.96%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 50.79
Quick Ratio 50.79
Altman-Z 68.69
F-ScoreN/A
WACC10.92%
ROIC/WACCN/A
Cap/Depr(3y)272%
Cap/Depr(5y)N/A
Cap/Sales(3y)12896.8%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-7.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-66.67%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-56.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-47.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-49.83%
OCF growth 3YN/A
OCF growth 5YN/A

DATACENTREX INC / DTCX Fundamental Analysis FAQ

What is the ChartMill fundamental rating of DATACENTREX INC (DTCX) stock?

ChartMill assigns a fundamental rating of 2 / 10 to DTCX.


What is the valuation status of DATACENTREX INC (DTCX) stock?

ChartMill assigns a valuation rating of 0 / 10 to DATACENTREX INC (DTCX). This can be considered as Overvalued.


How profitable is DATACENTREX INC (DTCX) stock?

DATACENTREX INC (DTCX) has a profitability rating of 1 / 10.